MENASHE BAR ELI to Melanoma
This is a "connection" page, showing publications MENASHE BAR ELI has written about Melanoma.
Connection Strength
5.631
-
Why is melanoma so metastatic? Pigment Cell Melanoma Res. 2014 Jan; 27(1):19-36.
Score: 0.140
-
Crossing the junction in the gap of melanoma brain metastasis. Pigment Cell Melanoma Res. 2013 Jul; 26(4):435-7.
Score: 0.135
-
Driving transcriptional regulators in melanoma metastasis. Cancer Metastasis Rev. 2012 Dec; 31(3-4):621-32.
Score: 0.132
-
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. Cancer Res. 2012 Nov 15; 72(22):5757-66.
Score: 0.130
-
The sweet and bitter sides of galectins in melanoma progression. Pigment Cell Melanoma Res. 2012 Sep; 25(5):592-601.
Score: 0.128
-
PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res. 2011 Nov 01; 71(21):6561-6.
Score: 0.122
-
A phase II study of gefitinib in patients with metastatic melanoma. Melanoma Res. 2011 Aug; 21(4):357-63.
Score: 0.120
-
Searching for the 'melano-miRs': miR-214 drives melanoma metastasis. EMBO J. 2011 May 18; 30(10):1880-1.
Score: 0.118
-
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res. 2011 May 15; 71(10):3494-504.
Score: 0.117
-
The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target. Oncotarget. 2011 Jan-Feb; 2(1-2):8-17.
Score: 0.115
-
Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc Natl Acad Sci U S A. 2011 Jan 11; 108(2):626-31.
Score: 0.115
-
Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Semin Cancer Biol. 2011 Apr; 21(2):83-8.
Score: 0.115
-
CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma. PLoS One. 2010 Aug 27; 5(8):e12452.
Score: 0.113
-
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem. 2009 Oct 16; 284(42):28845-55.
Score: 0.105
-
Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res. 2009 Aug 15; 69(16):6730-7.
Score: 0.105
-
Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. J Biol Chem. 2009 Sep 18; 284(38):26194-206.
Score: 0.104
-
Inflammation and melanoma metastasis. Pigment Cell Melanoma Res. 2009 Jun; 22(3):257-67.
Score: 0.102
-
Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. Am J Pathol. 2008 Dec; 173(6):1839-52.
Score: 0.099
-
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res. 2008 Nov 01; 68(21):9078-86.
Score: 0.099
-
Transcriptional control of the melanoma malignant phenotype. Cancer Biol Ther. 2008 Jul; 7(7):997-1003.
Score: 0.097
-
Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. Am J Clin Dermatol. 2008; 9(5):307-11.
Score: 0.094
-
Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer Metastasis Rev. 2007 Dec; 26(3-4):359-71.
Score: 0.093
-
The HOG-GLI face of melanoma. Pigment Cell Res. 2007 Oct; 20(5):341-2.
Score: 0.092
-
Searching for the Achilles' heel of melanoma cells: new treatment modalities. Pigment Cell Melanoma Res. 2008 Oct; 21(5):505-6.
Score: 0.091
-
ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis. Cancer Res. 2007 Jun 01; 67(11):5258-66.
Score: 0.090
-
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res. 2006 Nov 15; 12(22):6709-15.
Score: 0.087
-
Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther. 2007 Feb; 14(4):316-23.
Score: 0.086
-
Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 2006 Oct; 19(5):395-405.
Score: 0.086
-
Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. J Invest Dermatol. 2007 Feb; 127(2):387-93.
Score: 0.085
-
Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction. Cancer Res. 2005 Dec 01; 65(23):11185-92.
Score: 0.081
-
Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem. 2006 Feb 03; 281(5):2911-22.
Score: 0.081
-
The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Res. 2005 Feb 01; 65(3):692-7.
Score: 0.077
-
Regulation of gene expression in melanoma: new approaches for treatment. J Cell Biochem. 2005 Jan 01; 94(1):25-38.
Score: 0.076
-
Construction and expression of intracellular anti-ATF-1 single chain Fv fragment: a modality to inhibit melanoma tumor growth and metastasis. Methods. 2004 Oct; 34(2):233-9.
Score: 0.075
-
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. J Clin Oncol. 2004 Jun 01; 22(11):2092-100.
Score: 0.073
-
Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo. J Invest Dermatol. 2004 Feb; 122(2):400-5.
Score: 0.071
-
Gene expression profiling of human cutaneous melanoma: are we there yet? Cancer Biol Ther. 2004 Jan; 3(1):121-3.
Score: 0.071
-
Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma. J Biol Chem. 2003 Nov 21; 278(47):46632-42.
Score: 0.070
-
Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. Mol Cancer Ther. 2003 Aug; 2(8):753-63.
Score: 0.069
-
Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene. 2003 May 19; 22(20):3130-7.
Score: 0.068
-
Transcriptional regulation of metastasis-related genes in human melanoma. Clin Exp Metastasis. 2003; 20(3):251-63.
Score: 0.066
-
Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Cancer Res. 2002 Sep 01; 62(17):5106-14.
Score: 0.065
-
Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biol Ther. 2002 Sep-Oct; 1(5):459-65.
Score: 0.065
-
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 2002 Jul; 161(1):125-34.
Score: 0.064
-
Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo. Oncogene. 2001 Jun 07; 20(26):3363-75.
Score: 0.059
-
Gene regulation in melanoma progression by the AP-2 transcription factor. Pigment Cell Res. 2001 Apr; 14(2):78-85.
Score: 0.059
-
Targeting the ATF-1/CREB transcription factors by single chain Fv fragment in human melanoma: potential modality for cancer therapy. Crit Rev Immunol. 2001; 21(1-3):275-86.
Score: 0.058
-
Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol Cell Biochem. 2000 Sep; 212(1-2):19-28.
Score: 0.056
-
Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment. Oncogene. 2000 May 18; 19(22):2721-30.
Score: 0.055
-
Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res. 1999 Jul; 19(7):697-703.
Score: 0.052
-
Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology. 1999; 67(1):12-8.
Score: 0.050
-
Role of AP-2 in tumor growth and metastasis of human melanoma. Cancer Metastasis Rev. 1999; 18(3):377-85.
Score: 0.050
-
Molecular changes in human melanoma metastasis. Histol Histopathol. 1998 10; 13(4):1225-31.
Score: 0.049
-
CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem. 1998 Sep 18; 273(38):24884-90.
Score: 0.049
-
Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J. 1998 Aug 03; 17(15):4358-69.
Score: 0.049
-
Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem. 1998 Jun 26; 273(26):16501-8.
Score: 0.048
-
Molecular mechanisms of melanoma metastasis. J Cell Physiol. 1997 Nov; 173(2):275-8.
Score: 0.046
-
Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene. 1997 Oct 23; 15(17):2069-75.
Score: 0.046
-
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 1997 Oct; 151(4):1105-13.
Score: 0.046
-
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 1997 Jun 01; 57(11):2295-303.
Score: 0.045
-
Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene. 1996 Dec 05; 13(11):2339-47.
Score: 0.043
-
Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin Cancer Res. 1996 Dec; 2(12):1969-79.
Score: 0.043
-
A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res. 1996 Jan 15; 56(2):254-8.
Score: 0.041
-
Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis. Oncogene. 1995 Oct 05; 11(7):1399-402.
Score: 0.040
-
Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 1995 Aug 15; 55(16):3669-74.
Score: 0.040
-
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int J Cancer. 2015 Mar 15; 136(6):1296-307.
Score: 0.037
-
Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res. 1994 Sep-Oct; 14(5A):1759-65.
Score: 0.037
-
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest. 2013 Jun; 123(6):2703-18.
Score: 0.034
-
Therapeutic destruction of insulin receptor substrates for cancer treatment. Cancer Res. 2013 Jul 15; 73(14):4383-94.
Score: 0.034
-
Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res. 1993 Feb; 3(1):35-41.
Score: 0.033
-
Chitosan hydrogel for localized gene silencing. Cancer Biol Ther. 2011 May 01; 11(9):839-45.
Score: 0.029
-
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. Cancer Res. 2009 Oct 01; 69(19):7538-47.
Score: 0.026
-
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans. Cancer Res. 2008 Oct 15; 68(20):8419-28.
Score: 0.025
-
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer. 2008 Sep 02; 99(5):734-40.
Score: 0.024
-
Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell. 2007 May; 11(5):447-60.
Score: 0.022
-
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. Cancer Res. 2007 Feb 15; 67(4):1502-12.
Score: 0.022
-
Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene. 2007 Mar 15; 26(12):1739-47.
Score: 0.021
-
Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res. 2004 Oct 15; 64(20):7361-9.
Score: 0.019
-
Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res. 2004 Jan 01; 64(1):146-51.
Score: 0.018
-
Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res. 1998 Jul 01; 58(13):2733-6.
Score: 0.012
-
Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand. Int J Cancer. 1997 Nov 27; 73(5):769-74.
Score: 0.012
-
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. Am J Pathol. 2012 May; 180(5):2170-81.
Score: 0.008
-
Expression of ki-ras oncogene in tumor cell variants exhibiting different metastatic capabilities. Int J Cancer. 1985 Feb 15; 35(2):227-30.
Score: 0.005